Table 2.
Median Overall Survival (Months) | Multivariate analysis | ||||
Group | NACRT | NACRT + AC | P | Hazard Ratio | P |
Overall Cohort | 36.5 (35.3 - 38.3) | 35.5 (31.1 - 43.0) | 0.380 | 0.77 (0.66 – 0.89) | <0.001 |
cN+/pN+ | 22.7 (20.9 - 24.6) | 27.8 (24.2 - 32.6) | 0.010 | 0.82 (0.67 - 1.00) | 0.048 |
cN+/pN0 | 43.7 (40.5 - 50.7) | 64.4 (41.9 - NR) | 0.019 | 0.59 (0.39 - 0.88) | 0.009 |
cN0/pN+ | 24.9 (21.7 - 27.3) | 31.4 (24.5 - 43.5) | 0.077 | 0.76 (0.54 - 1.06) | 0.105 |
cN0/pN0 | 49.1 (43.6 - 55.4) | 48.3 (35.7 - NR) | 0.253 | 0.73 (0.41-1.30) | 0.253 |
AC, adjuvant chemotherapy; HR, hazard ratio; NACRT, neoadjuvant chemoradiotherapy; NR, not reached.